• β-Galactosidase Reporter Assay Kit: Cross-Host Insight

  2026-10-04

  The β-Galactosidase Reporter Assay Kit offers a useful conceptual lens for interpreting promoter-driven expression across biological systems. This evidence-focused guide connects reporter signal, cross-kingdom promoter design, and the limits of translating relative expression between Escherichia coli and Saccharomyces cerevisiae.

• Aedes aegypti Xenobiotic Transport and OCT Response

  2026-10-03

  Kennel and Rouhier examined how structurally distinct xenobiotics affect clearance, mortality, and expression of putative organic cation transporters in Aedes aegypti. The study’s main contribution is evidence that chemical structure may influence excreted material and physiological outcome more strongly than short-term changes in candidate transporter transcripts, while leaving the underlying transport mechanisms unresolved.

• Tioconazole Workflows for Antifungal Research

  2026-10-02

  Tioconazole offers a practical mechanistic benchmark for connecting fungal cytochrome P450 inhibition with ergosterol loss, membrane injury, and growth suppression. This workflow-centered guide covers stock preparation, concentration–response testing, fungal infection models, cross-domain assay design, and troubleshooting for reproducible antifungal drug development.

• Rapakinin Reveals a PGI₂–IP–CCK1 Vasorelaxation Pathway

  2026-10-01

  The reference study shows that rapakinin, the Arg-Ile-Tyr peptide from rapeseed protein, relaxes mesenteric arteries from spontaneously hypertensive rats through a prostaglandin I₂–IP receptor pathway that signals downstream to CCK1 receptors. Its weak dependence on nitric oxide synthase and bradykinin B2 signaling reframes how peptide-derived antihypertensive activity can be investigated in vascular tone regulation studies.

• ATG4B Nuclear Translocation Links Energy Deficiency to AML

  2026-10-01

  The reference study identifies an energy-sensitive mechanism in which nuclear translocation of ATG4B disrupts PRMT1-dependent MRE11 methylation, weakening DNA repair and accelerating acute myeloid leukemia progression. Its combination of mechanistic studies, patient-derived AML models, genetically induced leukemia, and xenograft experiments positions ATG4B inhibition as a preclinical strategy for reducing genomic instability.

• Betaine hydrochloride in Inflammation Assays

  2026-09-30

  Betaine hydrochloride provides a water-soluble, tunable matrix variable for enzyme, protease, cell-based, and inflammation-linked assays. This workflow separates what the reagent can control experimentally from the anti-inflammatory activity reported for oridonin, helping researchers build cleaner mechanistic comparisons.

• Cy5-UTP for RNA Labeling and R-Loop Imaging

  2026-09-30

  Cy5-UTP enables direct far-red visualization of RNA generated by T7 transcription, supporting FISH, expression-array, and single-molecule assays. This guide translates its labeling chemistry into practical workflows for studying RNA–DNA hybrids and replication conflicts while highlighting controls, optimization points, and limitations.

• ATRX-Deficient Glioma Sensitivity to RTK Inhibitors

  2026-09-29

  The reference study identifies a genotype-linked vulnerability in high-grade glioma: ATRX-deficient cells show increased sensitivity to multi-targeted receptor tyrosine kinase and PDGFR inhibitors. Its drug-screening and temozolomide combination data support ATRX status as a potentially useful stratification variable for interpreting RTK inhibitor studies, while remaining preclinical.

• Patient-Derived Gastric Cancer Assembloids

  2026-09-29

  This 2025 study develops patient-derived gastric cancer assembloids by combining matched tumor organoids with tumor-derived stromal subpopulations. The model reveals that stromal composition reshapes gene expression and drug sensitivity, providing a more physiologically relevant platform for resistance studies and personalized therapeutic screening.

• Trilaurin: Solubility, QC, and Workflow Setup

  2026-09-28

  Trilaurin, also called Glycerol Tridodecanoate, is a defined C12 triacylglycerol for lipid formulation development and enzyme-substrate workflows, with practical solubility options in DMSO and ethanol. It should not be treated as water-soluble or as evidence of biological efficacy; formulation, animal-study, cosmetic, and biocatalytic applications require application-specific validation.

• Fiber Density Rebuilds Annulus Fibrosus Matrix Patterns

  2026-09-28

  This study shows that changing the fiber density of composition-matched electrospun scaffolds can shift annulus fibrosus cells toward distinct collagen-producing phenotypes. Its findings connect scaffold microarchitecture with mechanotransduction and suggest a design strategy for recreating, rather than merely closing, the annulus fibrosus defect.

• Galectin-1–FIP200 Signaling in Hepatic Steatosis

  2026-09-27

  The study identifies a direct interaction between galectin-1 and FIP200 as a mechanism that suppresses autophagy and promotes hepatic steatosis, dyslipidemia, and insulin resistance. Its combination of mouse overexpression, proteomic profiling, binding analysis, and interaction-disrupting mutations provides a framework for testing how autophagy control contributes to metabolic liver disease.

• BTK Inhibition: From Mechanism to Translation

  2026-09-26

  Explore how PCI-32765 enables rigorous BTK pathway studies, from B-cell receptor signaling and CLL models to translationally grounded experimental design.

• α-Bungarotoxin for Cholinergic Blockade Research

  2026-09-25

  Use α-Bungarotoxin to test whether α7 nicotinic receptor signaling is necessary for a cellular or tissue response—not merely associated with it. A recent placental ischemia study illustrates this antagonist-based strategy, while the workflow below adapts it for carefully controlled cell assays and neuroscience research.

• Hepatocyte Arrb2 and 6-ketoLCA in Liver IRI

  2026-09-25

  This study identifies hepatocyte Arrb2 as a regulator of a metabolite-linked interaction between liver cells and macrophages during ischemia–reperfusion injury. Its findings support a protective pathway involving 6-ketoLCA and M2 macrophage polarization, while leaving important questions about the pathway’s molecular details and clinical translation open.

7675 records 1/512 page Next 12345 下5页 Last page